SynthesisAnnals of hematology2025

Comparative efficacy and safety of BCMA-targeted CAR T cells and BiTEs in relapsed/refractory multiple myeloma: a meta-analysis of interventional and real-world studies.

Pisanupong Techaapornkun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.